Novo Nordisk halves Ozempic price in US

Ozempic is getting cheaper in the US. Novo Nordisk, the Danish pharma giant behind the GLP-1 diabetes and weight-loss drug, said it halved the monthly cost to $499 for patients without health insurance. Novo Nordisk has struggled in the US market this year: It was slow to introduce a…
|
||||
You Might Like |